Dementia Management Training Programme for Primary Health Care Providers
1 juin 2026 mis à jour par: Xinying Lin, Fujian Medical University
Application and Effectiveness of a RE-AIM-Based Dementia Management Competency Training Program for Primary Health Care Providers: A Cluster Randomized Controlled Trial
This study aims to evaluate the effectiveness and implementation outcomes of a dementia management competency training program for primary healthcare workers.
A cluster randomized controlled trial will be conducted among primary healthcare institutions in Nanping, Fujian Province, China.
Eligible primary health care providers will be recruited from community health service centers and township health centers.Participating institutions will be randomized in a 1:1 ratio to either a structured dementia management training group or a self-directed learning control group.
The intervention group will receive a 12-week blended training program, including online learning, an in-person skills workshop, and case-based practice supervision.
The control group will receive self-directed online learning materials.
Outcomes will be assessed at baseline, immediately after the intervention, and 3 months after the intervention.
The primary outcome is the change in dementia knowledge, measured using the Dementia Knowledge Assessment Scale.
Secondary outcomes include dementia-related attitudes, dementia management practice competency, self-reported dementia management behaviors, objective screening and referral-related indicators, and implementation outcomes based on the RE-AIM framework.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Description détaillée
This study uses a hybrid effectiveness-implementation design integrating a cluster randomized controlled trial and implementation evaluation.
The trial will assess the effectiveness of a dementia management competency training program for primary health care providers at both the individual and organizational levels.
At the individual level, the study will evaluate the effects of the training on dementia knowledge, attitudes, practice competency, and dementia management-related clinical behaviors.
At the organizational level, the study will examine reach, adoption, implementation quality, and maintenance of the training program in real-world primary healthcare settings.The study will be conducted in community health service centers and township health centers in Nanping, Fujian Province, China.
Primary healthcare institutions will serve as clusters.
Approximately 16 institutions will be recruited and randomized to the intervention or control group at a 1:1 ratio, with approximately 20 primary health care providers recruited from each institution.The intervention group will receive a 12-week structured blended training program named "Hand in Hand Along the Memory Path".
During weeks 1-4, participants will complete seven online learning modules, with a total learning duration of approximately 3 hours.
At the end of week 4, participants will attend an in-person skills workshop of approximately 2 hours, focusing on standardized use of cognitive screening and assessment tools.
During weeks 5-12, participants will take part in online case-based supervision every two weeks and complete practice tasks related to cognitive screening and dementia management.The control group will receive self-directed online learning materials, including the same knowledge module videos and text-based materials.
However, the control group will not receive structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.Quantitative data will be collected at baseline, immediately after the intervention, and 3 months after the intervention.
Semi-structured interviews will be conducted 3 months after the intervention to explore participants' experiences, implementation barriers and facilitators, and factors affecting maintenance.
Quantitative and qualitative findings will be integrated according to the RE-AIM framework.
Type d'étude
Interventionnel
Inscription (Estimé)
240
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Xinying Lin
- Numéro de téléphone: +86 18965733707
- E-mail: xinyinglin0416@163.com
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
Primary healthcare workers aged 18 years or older
Registered healthcare professionals holding a formal license issued by the national health authority
At least 1 year of work experience
Able to access the internet using a computer, tablet, or mobile phone
Currently working in a participating community health service center or township health center
Willing to participate in the study and provide written informed consent
Exclusion Criteria:
Personnel who do not directly participate in patient disease management, including logistics or auxiliary staff
Interns, trainees, or students
Individuals currently participating in other similar dementia training interventions
Individuals planning to leave their current institution within the next 12 months
Individuals who refuse to participate in the study or decline to provide written informed consent
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Structured Dementia Management Training Group
Participants in this group will receive a 12-week structured blended dementia management competency training program.
The program includes online learning modules, an in-person skills workshop, case-based supervision, and practice tasks designed to improve dementia knowledge, attitudes, practice competency, and dementia management-related behaviors among primary health care providers.
|
The intervention is a 12-week blended training program.
During weeks 1-4, participants will complete seven online modules with a total learning duration of approximately 3 hours.
At the end of week 4, participants will attend a 2-hour in-person skills workshop focusing on standardized cognitive screening and assessment.
During weeks 5-12, participants will participate in online case-based supervision every two weeks and complete practice tasks, including cognitive screening records and dementia management case records.
Autres noms:
|
|
Comparateur actif: Self-directed Learning Control Group
Participants in this group will receive self-directed online learning materials related to dementia management.
The materials include knowledge module videos and text-based resources but do not include structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.
|
Participants will be provided with online dementia-related learning materials and will arrange their own learning time and place.
No structured completion requirements, assessments, in-person activities, or expert supervision will be provided.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in dementia knowledge score
Délai: Baseline, immediately after the intervention, and 3 months after the intervention
|
Dementia knowledge will be measured using the Dementia Knowledge Assessment Scale.
The primary outcome is the change in total DKAS score from baseline to immediately after the 12-week intervention.
Higher scores indicate greater dementia knowledge.
|
Baseline, immediately after the intervention, and 3 months after the intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in dementia-related attitudes and confidence
Délai: Baseline, immediately after the intervention, and 3 months after the intervention
|
Dementia-related attitudes and confidence will be measured using the General Practitioners' Attitudes and Confidence Scale for Dementia.
Higher scores indicate more positive attitudes and greater confidence.
|
Baseline, immediately after the intervention, and 3 months after the intervention
|
|
Change in dementia management practice competency
Délai: Baseline, immediately after the intervention, and 3 months after the intervention
|
Dementia management practice competency was measured using the Dementia Management Practice Competency Scale for Primary Care, which was developed by the research team.
Higher scores on the scale indicate greater dementia management practice competency.
|
Baseline, immediately after the intervention, and 3 months after the intervention
|
|
Change in self-reported dementia management-related behaviors
Délai: Baseline, immediately after the intervention, and 3 months after the intervention
|
Participants will report the frequency of dementia management-related behaviors during the past month, including cognitive screening, identification of suspected cognitive impairment, referral recommendation, communication with patients or family members, and dementia-related health education.
|
Baseline, immediately after the intervention, and 3 months after the intervention
|
|
Cognitive screening implementation rate
Délai: Baseline, immediately after the intervention, and 3 months after the intervention
|
The cognitive screening implementation rate will be calculated as the number of patients aged 65 years or older who received cognitive screening divided by the total number of patients aged 65 years or older seen during the same period, multiplied by 100%.
|
Baseline, immediately after the intervention, and 3 months after the intervention
|
|
Referral recommendation documentation rate
Délai: Baseline, immediately after the intervention, and 3 months after the intervention
|
The referral recommendation documentation rate will be calculated as the number of screen-positive patients with documented referral recommendations divided by the total number of screen-positive patients, multiplied by 100%.
|
Baseline, immediately after the intervention, and 3 months after the intervention
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Online course completion rate
Délai: Immediately after the intervention
|
The proportion of intervention group participants who complete all online learning modules.
|
Immediately after the intervention
|
|
In-person workshop attendance rate
Délai: Immediately after the intervention
|
The proportion of intervention group participants who attend the in-person skills workshop.
|
Immediately after the intervention
|
|
Practice task completion rate
Délai: Immediately after the intervention
|
The proportion of intervention group participants who submit the required screening records and case management records.
|
Immediately after the intervention
|
|
Online supervision participation rate
Délai: Immediately after the intervention
|
The number of online supervision sessions attended divided by the number of scheduled supervision sessions.
|
Immediately after the intervention
|
|
Training satisfaction and acceptability
Délai: Immediately after the intervention
|
Satisfaction and acceptability will be assessed using a self-designed questionnaire with Likert-scale items and open-ended questions.
|
Immediately after the intervention
|
|
Institutional maintenance of dementia-related practices
Délai: 3 months after the intervention
|
Institutional maintenance will be assessed using a questionnaire completed by institutional managers, including whether cognitive screening, result explanation, referral recommendation, or related training continues after the intervention.
|
3 months after the intervention
|
|
Barriers and facilitators to implementation and maintenance
Délai: 3 months after the intervention
|
Semi-structured interviews will be conducted with intervention group participants and institutional managers to explore implementation experiences, barriers, facilitators, and suggestions for optimization.
|
3 months after the intervention
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
15 juin 2026
Achèvement primaire (Estimé)
15 septembre 2026
Achèvement de l'étude (Estimé)
15 décembre 2026
Dates d'inscription aux études
Première soumission
26 mai 2026
Première soumission répondant aux critères de contrôle qualité
26 mai 2026
Première publication (Réel)
1 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
3 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
1 juin 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- K2026-04-027
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .